BR-TD-1001

· Boryung Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BR-TD-1001, covering 2020-11-20 to 2020-11-20. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children [Phase 3]

See pricing